COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 968: Articles 9671-9680  | Next

Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
Jolliffe, D. A., Faustini, S. E., Holt, H., Perdek, N., Maltby, S., Talaei, M., Greenig, M., Vivaldi, G., Tydeman, F., Symons, J., Davies, G. A., Lyons, R., Kee, F., Sheikh, A., Shaheen, S. O., Richter, A., Martineau, A. R.
10.1101/2022.02.14.22270930 — Posted: 2022-02-15
Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC
Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., Lustig, Y.
10.1101/2022.02.15.22270948 — Posted: 2022-02-15 Discussion: Onsite
The impact of changes in mental health services in response to COVID-19 on people with mental health conditions: protocol for a rapid review
Yu, G., Craig, D., Fu, Y.
10.1101/2022.02.15.22270931 — Posted: 2022-02-15
SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Lewis, H. C., Ware, H., Whelan, M. G., Subissi, L., Li, Z., Ma, X., Nardone, A., Valenciano, M., Cheng, B., Noel, K. C., Cao, C., Yanes-Lane, M., Herring, B. L., Talisuna, A. O., Nsenga, N., Balde, T., Clifton, D., Van Kerkhove, M., Buckeridge, D., Bobrovitz, N., Okeibunor, J. C., Arora, R. K., BERGERI, I., the UNITY Studies Collaborator Group
10.1101/2022.02.14.22270934 — Posted: 2022-02-15
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
Doykov, I., Spiewak, J., Gilmour, K. C., Gibbons, J. M., Pade, C., McKnight, A., Noursadeghi, M., Maini, M., Manisty, C., Treibel, T. A., Captur, G., Fontana, M., Boyton, R., Altmann, D. M., Brooks, T., Semper, A., Moon, J., Mills, K., Heywood, W. E.
10.1101/2022.02.14.22270845 — Posted: 2022-02-15
Experiences of the physicians in the largest COVID-19 dedicated hospital of Bangladesh about COVID-19 and its aftermath
Mahmud, R., Banu, S. S., Sultana, N., Monayem, F. B., Datta, P. K., Hoque, M. M., Habib, S. M. H. R., Abedin, J., Islam, M. F., Arifuzzaman, M., Islam, M. K., Deb, S. R., Chowdhury, A. H., Ahmed, K. G. U., Miah, M. T., Rahman, M. M.
10.1101/2022.02.14.22270965 — Posted: 2022-02-15
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
Nanthapisal, S., Puthanakit, T., Jaru-Ampornpan, P., Nantanee, R., Sodsai, P., Himananto, O., Sophonphan, J., Suchartlikitwong, P., Hiransuthikul, N., Angkasekwinai, P., Tangsathapornpong, A., Hirankarn, N.
10.1101/2022.02.15.22270974 — Posted: 2022-02-15
Brain cortical changes are related to inflammatory biomarkers in hospitalized SARS-CoV-2 patients with neurological symptoms
Sanabria Diaz, G., Maja Etter, M., Melie Garcia, L., Lieb, J. M., Psychogios, M.-N., Hutter, G., Granziera, C.
10.1101/2022.02.13.22270662 — Posted: 2022-02-15
Efficacy of Lactococcus lactis strain plasma (LC-Plasma) in easing symptoms in patients with mild coronavirus disease 2019 (COVID-19): protocol for an exploratory, multicenter, double-blinded, randomized controlled trial (PLATEAU study)
Yamamoto, K., Hosogaya, N., Inoue, T., Jounai, K., Tsuji, R., Fujiwara, D., Yanagihara, K., Izumikawa, K., Mukae, H.
10.1101/2022.02.13.22270913 — Posted: 2022-02-15
An observation and restoration model for the COVID-19 incidence curves
Alvarez, L., Morel, J.-D., Morel, J.-M.
10.1101/2022.02.13.22270901 — Posted: 2022-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).